Skye Bioscience, Inc.
SKYE
$1.97
-$0.0809-3.95%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 59.22M | 68.42M | 67.41M | 74.12M | 83.47M |
| Total Receivables | 14.60K | 13.20K | 12.70K | 548.70K | 551.90K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 575.40K | 202.00K | 664.60K | 1.10M | 640.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.21M | 2.20M | 11.72M | 11.24M | 9.91M |
| Total Current Assets | 63.03M | 70.83M | 79.81M | 87.00M | 94.57M |
|
|
|||||
| Total Current Assets | 63.03M | 70.83M | 79.81M | 87.00M | 94.57M |
| Net Property, Plant & Equipment | 1.71M | 1.88M | 1.70M | 248.80K | 256.90K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 53.90K | 53.90K | 26.30K | 8.30K | 8.30K |
| Total Assets | 64.79M | 72.76M | 81.54M | 87.26M | 94.84M |
|
|
|||||
| Total Accounts Payable | 1.71M | 569.30K | 780.00K | 1.08M | 1.10M |
| Total Accrued Expenses | 1.50M | 1.77M | 2.97M | 2.25M | 3.84M |
| Short-term Debt | -- | -- | -- | 4.86M | 4.61M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 188.60K | 182.40K | 82.90K | 79.20K | 75.50K |
| Total Finance Division Other Current Liabilities | 1.91M | 1.82M | 1.79M | 6.05M | 6.18M |
| Total Other Current Liabilities | 1.91M | 1.82M | 1.79M | 6.05M | 6.18M |
| Total Current Liabilities | 5.32M | 4.34M | 5.62M | 14.32M | 15.80M |
|
|
|||||
| Total Current Liabilities | 5.32M | 4.34M | 5.62M | 14.32M | 15.80M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | 4.86M | 4.61M |
| Capital Leases | 223.50K | 273.20K | 108.10K | 129.90K | 151.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 5.54M | 4.61M | 5.73M | 14.45M | 15.95M |
|
|
|||||
| Common Stock & APIC | 201.30M | 199.10M | 197.01M | 190.11M | 188.29M |
| Retained Earnings | -142.05M | -130.95M | -121.20M | -117.30M | -109.40M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 59.25M | 68.15M | 75.80M | 72.81M | 78.88M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 59.25M | 68.15M | 75.80M | 72.81M | 78.88M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 59.25M | 68.15M | 75.80M | 72.81M | 78.88M |
|
|
|||||